The Evolving Epidemiology of Amyloidosis

por Wechalekar, Ashutosh D.
Publicado 2021

Extensive cardiac FDG uptake in a patient with AL amyloidosis

por Hatipoglu, Suzan, Wechalekar, Ashutosh D., Wechalekar, Kshama
Publicado 2023

AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: JACC: CardioOncology State-of-the-Art Review

por Wechalekar, Ashutosh D., Fontana, Marianna, Quarta, C. Cristina, Liedtke, Michaela
Publicado 2022

Thoracic amyloidomas: Two case reports of an evasive diagnosis

por Cresner, Rosie, Mahmood, Shameem, Chen, Jane, Rowan, Camilla, Wechalekar, Ashutosh D
Publicado 2014

Updates in Cardiac Amyloidosis: A Review

por Banypersad, Sanjay M., Moon, James C., Whelan, Carol, Hawkins, Philip N., Wechalekar, Ashutosh D.
Publicado 2012

Extracardiac (18)F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds

por Wagner, T., Page, J., Burniston, M., Skillen, A., Ross, J. C., Manwani, R., McCool, D., Hawkins, P. N., Wechalekar, Ashutosh D.
Publicado 2018

A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis

por Sharpley, Faye A., Manwani, Richa, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Gillmore, Julian D., Whelan, Carol J., Fontana, Marianna, Hawkins, Philip N., Wechalekar, Ashutosh D.
Publicado 2019

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria

por Sharpley, Faye A., Fontana, Marianna, Martinez-Naharro, Ana, Manwani, Richa, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Gillmore, Julian D., Whelan, Carol J., Hawkins, Philip N., Wechalekar, Ashutosh D.
Publicado 2020

Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis

por Ravichandran, Sriram, Law, Steven, Mahmood, Shameem, Wisniowski, Brenden, Foard, Darren, Fontana, Marianna, Martinez-Naharro, Ana, Whelan, Carol, Gillmore, Julian D., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.
Publicado 2022

Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib

por Ravichandran, Sriram, Cohen, Oliver C., Law, Steven, Foard, Darren, Fontana, Marianna, Martinez-Naharro, Ana, Whelan, Carol, Gillmore, Julian D., Lachmann, Helen J., Sachchithanantham, Sajitha, Mahmood, Shameem, Hawkins, Philip N., Wechalekar, Ashutosh D.
Publicado 2021

The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis

por Rezk, Tamer, Gilbertson, Janet A, Mangione, P Patrizia, Rowczenio, Dorota, Rendell, Nigel B, Canetti, Diana, Lachmann, Helen J, Wechalekar, Ashutosh D, Bass, Paul, Hawkins, Philip N, Bellotti, Vittorio, Taylor, Graham W, Gillmore, Julian D
Publicado 2019

The impact and importance of achieving a complete haematological response prior to renal transplantation in AL amyloidosis

por Cohen, Oliver C., Law, Steven, Lachmann, Helen J., Sharpley, Faye, Ravichandran, Sriram, Mahmood, Shameem, Sachchithanantham, Sajitha, Whelan, Carol J., De Azcona Naharro, Ana Martinez, Fontana, Marianna, Hawkins, Philip N., Gillmore, Julian D., Wechalekar, Ashutosh D.
Publicado 2020

A randomized phase 3 study of ixazomib–dexamethasone versus physician’s choice in relapsed or refractory AL amyloidosis

por Dispenzieri, Angela, Kastritis, Efstathios, Wechalekar, Ashutosh D., Schönland, Stefan O., Kim, Kihyun, Sanchorawala, Vaishali, Landau, Heather J., Kwok, Fiona, Suzuki, Kenshi, Comenzo, Raymond L., Berg, Deborah, Liu, Guohui, Kumar, Arun, Faller, Douglas V., Merlini, Giampaolo
Publicado 2021

Systemic Amyloidosis in England: an epidemiological study

por Pinney, Jennifer H, Smith, Colette J, Taube, Jessi B, Lachmann, Helen J, Venner, Christopher P, Gibbs, Simon D J, Dungu, Jason, Banypersad, Sanjay M, Wechalekar, Ashutosh D, Whelan, Carol J, Hawkins, Philip N, Gillmore, Julian D
Publicado 2013

Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma

por Lecat, Catherine S. Y., Taube, Jessica B., Wilson, William, Carmichael, Jonathan, Parrish, Christopher, Wallis, Gabriel, Kyriakou, Charalampia, Lee, Lydia, Mahmood, Shameem, Papanikolaou, Xenofon, Rabin, Neil K., Sive, Jonathan, Wechalekar, Ashutosh D., Yong, Kwee, Cook, Gordon, Popat, Rakesh
Publicado 2021

T1 mapping and survival in systemic light-chain amyloidosis

por Banypersad, Sanjay M., Fontana, Marianna, Maestrini, Viviana, Sado, Daniel M., Captur, Gabriella, Petrie, Aviva, Piechnik, Stefan K., Whelan, Carol J., Herrey, Anna S., Gillmore, Julian D., Lachmann, Helen J., Wechalekar, Ashutosh D., Hawkins, Philip N., Moon, James C.
Publicado 2015

Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis

por Premkumar, Vikram J., Lentzsch, Suzanne, Pan, Samuel, Bhutani, Divaya, Richter, Joshua, Jagannath, Sundar, Liedtke, Michaela, Jaccard, Arnaud, Wechalekar, Ashutosh D., Comenzo, Raymond, Sanchorawala, Vaishali, Royer, Bruno, Rosenzweig, Michael, Valent, Jason, Schönland, Stefan, Fonseca, Rafael, Wong, Sandy, Kapoor, Prashant
Publicado 2021

Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy

por Law, Steven, Petrie, Aviva, Chacko, Liza, Cohen, Oliver C, Ravichandran, Sriram, Gilbertson, Janet A, Rowczenio, Dorota, Wechalekar, Ashutosh D, Martinez-Naharro, Ana, Lachmann, Helen J, Whelan, Carol J, Hutt, David F, Hawkins, Philip N, Fontana, Marianna, Gillmore, Julian D
Publicado 2022

Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA Trial

por Minnema, Monique C., Dispenzieri, Angela, Merlini, Giampaolo, Comenzo, Raymond L., Kastritis, Efstathios, Wechalekar, Ashutosh D., Grogan, Martha, Witteles, Ronald, Ruberg, Frederick L., Maurer, Mathew S., Tran, NamPhuong, Qin, Xiang, Vasey, Sandra Y., Weiss, Brendan M., Vermeulen, Jessica, Jaccard, Arnaud
Publicado 2022

Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis

por Quarta, Candida Cristina, Gonzalez-Lopez, Esther, Gilbertson, Janet A., Botcher, Nichola, Rowczenio, Dorota, Petrie, Aviva, Rezk, Tamer, Youngstein, Taryn, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Fontana, Marianna, Whelan, Carol J., Wechalekar, Ashutosh D., Hawkins, Philip N., Gillmore, Julian D.
Publicado 2017